Editorial
doi: 10.1016/j.jcin.2016.07.009.
The Last Detail: Platelets, Glycoprotein IIb/IIIa Antagonists, and Excipients
Affiliations
- PMID: 27539686
- DOI: 10.1016/j.jcin.2016.07.009
Item in Clipboard
Editorial
The Last Detail: Platelets, Glycoprotein IIb/IIIa Antagonists, and Excipients
JACC Cardiovasc Interv.
.
Free article
No abstract available
Keywords: GP IIb/IIIa antagonists; acute coronary syndromes(s); thrombocytopenia.
Comment on
-
Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial.JACC Cardiovasc Interv. 2016 Aug 22;9(16):1667-76. doi: 10.1016/j.jcin.2016.05.031. JACC Cardiovasc Interv. 2016. PMID: 27539685 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
